The behavior you’re trying to change is often just the surface.
What holds it in place are everyday defaults — familiar routines, shortcuts, workflow habits — hiding in plain sight.
We make the hidden visible
We apply habit science to identify the few most salient defaults sustaining a behavior — and design precise interventions that make change doable in practice.
SilboSpark is a healthcare behavioral strategy and activation consultancy.
Real world behaviors we help move
Delayed escalation to biologics in atopic dermatitis
Delayed dose titration in diabetes management
Quality of life impact not systematically surfaced
Support programs that exists but don’t activate at the time of need
Our Process
Use existing research to surface the defaults sustaining the current behavior — and the drivers beneath them.
Translate those insights into precise, behaviorally grounded interventions.
Build and refine the activation tools that operationalize the intervention.
When teams bring us in
-
When a specific behavior needs to be set intentionally from day one.*
Examples include -
Ensuring eligible patients are identified and tested
Establishing dosing cadence so starter doses don’t become long-term defaults
Structuring treatment conversations to surface quality-of-life impact early
Designing materials around how clinicians actually make decisions in practice
*The interventions we design are in addition to messaging.
-
When performance depends on shifting behaviors that have already become routine.*
Examples include -
Escalation to your brand is slower than forecast
Titration plateaus at lower doses than intended
Clinicians understand the data — but prescribing behavior isn’t shifting
Adherence drops after initiation despite education efforts
*The interventions we design are in addition to messaging.
Illustrative Examples
Diabetes
Surface Behavior
Patients remain on the starter dose instead of titrating to therapeutic levels.
What’s Hidden
The starting dose becomes the psychological default. Without a clearly framed destination, the starting dose feels like an endpoint rather than a step.
What We Did
Reframed the dosing journey around the therapeutic dose — leading with the higher therapeutic dose as the destination so the starter dose felt like a stepping-stone. Activation tools were redesigned to signal upward movement as expected progress.
Result
More patients advancing toward therapeutic dose.
Atopic Dermatitis
Surface Behavior
Escalation to biologic therapy occurs later than clinically appropriate.
What’s Hidden
Visit conversations prioritize visible symptoms. Quality-of-life burden isn’t systematically surfaced.
What We Did
Introduced structured QoL salience into routine visits and reframed escalation criteria around lived burden.
Result
Earlier, more confident escalation conversations.
Conference & Thought Leadership
American Academy of Dermatology Innovation Academy (July 2025)
Presented scientific poster on integrating psychodermatologic tools into routine dermatology practice to better surface quality-of-life burden and support timely treatment escalation.